There are several prognostic factors of clinico-pathologic colorectal carcinoma, including age, sex, tumor location, tumor size, histopathologic type, differentiation grade, depth of invasion, lymph node involvement, and KRAS / NRAS mutations status. This study aims to determine the correlation between KRAS / NRAS mutation status with some clinicopathologic prognostic factors. This research is an observational cross-sectional comparative study design using 24 samples
To explore the novel applications of histological factors by stratifying the prognostic markers of t...
Colorectal cancer (CRC) remains a major public health issue. The detection of parameters that affect...
Activation of oncogenes downstream the EGFR gene contributes to colorectal tumorigenesis and determi...
There are several prognostic factors of clinico-pathologic colorectal carcinoma, including age, sex,...
Abstract Background Colorectal cancer (CRC) originating from the right-sided or left-sided colon is ...
Background: KRAS mutations have a significant role in the consecutive activation of RAS-RAF-MEK-ERK ...
Several studies show that mutational profiles could influence treatment decisions in patients with m...
BACKGROUND: Mutations in the Kirsten Ras (KRAS) oncogene are common in colorectal cancer (CRC). The ...
prognostic associations of KRAS codon 61 and KRAS mutation prevalence in colorectal cancers was 40 %...
NRAS mutations occur in 3-5% of colorectal cancer. Differently from KRAS and BRAF mutations, the rol...
Stage I colorectal carcinoma has excellent prognosis, with 5-year survival rate up to 95%. The occur...
The RAS gene family is among the most studied and best characterized of the known cancer-related gen...
Background:Mutations in the Kirsten Ras (KRAS) oncogene are common in colorectal cancer (CRC). The r...
OBJECTIVE: KRAS and mismatch repair genes are two important molecular markers used in determining pr...
Abstract Background We evaluated the association between a KRAS mutational status and various clinic...
To explore the novel applications of histological factors by stratifying the prognostic markers of t...
Colorectal cancer (CRC) remains a major public health issue. The detection of parameters that affect...
Activation of oncogenes downstream the EGFR gene contributes to colorectal tumorigenesis and determi...
There are several prognostic factors of clinico-pathologic colorectal carcinoma, including age, sex,...
Abstract Background Colorectal cancer (CRC) originating from the right-sided or left-sided colon is ...
Background: KRAS mutations have a significant role in the consecutive activation of RAS-RAF-MEK-ERK ...
Several studies show that mutational profiles could influence treatment decisions in patients with m...
BACKGROUND: Mutations in the Kirsten Ras (KRAS) oncogene are common in colorectal cancer (CRC). The ...
prognostic associations of KRAS codon 61 and KRAS mutation prevalence in colorectal cancers was 40 %...
NRAS mutations occur in 3-5% of colorectal cancer. Differently from KRAS and BRAF mutations, the rol...
Stage I colorectal carcinoma has excellent prognosis, with 5-year survival rate up to 95%. The occur...
The RAS gene family is among the most studied and best characterized of the known cancer-related gen...
Background:Mutations in the Kirsten Ras (KRAS) oncogene are common in colorectal cancer (CRC). The r...
OBJECTIVE: KRAS and mismatch repair genes are two important molecular markers used in determining pr...
Abstract Background We evaluated the association between a KRAS mutational status and various clinic...
To explore the novel applications of histological factors by stratifying the prognostic markers of t...
Colorectal cancer (CRC) remains a major public health issue. The detection of parameters that affect...
Activation of oncogenes downstream the EGFR gene contributes to colorectal tumorigenesis and determi...